Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00076141 · ClinicalTrials.gov registry record
Relatively Healthy Male Veterans Observed Over Time to See What Types of Diseases Develop
A clinical trial, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- 991
- Enrollment target
NCT00076141: Completed study, sponsored by VA Office of Research and Development.
NCT00076141 is a clinical trial that has completed, run by VA Office of Research and Development. The registered enrollment target is 991 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00076141 has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- 991 participants
- Enrollment target
Study Summary
The purpose of this study is to gather a mixed racial group of relatively healthy male Veterans (for example, White, African-American, and Hispanic), who are at least 50 years of age. These men will be followed to see what types of diseases they develop and to determine if racial differences in lifestyle, blood test results, or genes are related to the types of diseases that are found. Diseases of particular interest are prostate cancer, other cancers, cardiovascular disease (for example, heart attacks and stroke), high blood pressure and diabetes. The group to be followed will consist of about 16,000 men recruited from about 40 VA Medical Centers across the country. Each man will be followed for at least five years depending on when he enters the study.
Primary Outcome
To determine whether differences in the prevalence of common chronic conditions affecting older Veterans among African-American and white male Veterans are explained by medical, lifestyle, dietary, or other risk factors.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 991 participants |
| Start Date | 2002-01-01 |
| Est. Completion | 2021-01-01 |
What the finished NCT00076141 record still lists
NCT00076141 is an observational study that tracks outcomes without assigning an intervention. The registered 991 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00076141 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00076141 about?
NCT00076141 is a clinical study titled "Relatively Healthy Male Veterans Observed Over Time to See What Types of Diseases Develop". The purpose of this study is to gather a mixed racial group of relatively healthy male Veterans (for example, White, African-American, and Hispanic), who are at least 50 years of age. These men will be followed to see what types of diseases they develop and to determine if racial differences in life...
What is the current status of trial NCT00076141?
This trial is currently completed. The enrollment target is 991 participants. The study started on 2002-01-01. Estimated completion is 2021-01-01.
Who is sponsoring clinical trial NCT00076141?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05987241 · 992 participants · Phase 2
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
- NCT05441709 · 990 participants · NA
Furthering Equity Through Infant Feeding EDucation and Support
- NCT06340646 · 990 participants · NA
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
- NCT06878261 · 990 participants · Phase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI